These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8035907)
1. Comparative study of the effects of mu, delta and kappa opioid agonists on 3H-dopamine uptake in rat striatum and nucleus accumbens. Das D; Rogers J; Michael-Titus AT Neuropharmacology; 1994 Feb; 33(2):221-6. PubMed ID: 8035907 [TBL] [Abstract][Full Text] [Related]
2. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex. Heijna MH; Padt M; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN Eur J Pharmacol; 1990 Jun; 181(3):267-78. PubMed ID: 2166675 [TBL] [Abstract][Full Text] [Related]
3. Opioid receptor-mediated inhibition of 3H-dopamine and 14C-acetylcholine release from rat nucleus accumbens slices. A study on the possible involvement of K+ channels and adenylate cyclase. Heijna MH; Hogenboom F; Mulder AH; Schoffelmeer AN Naunyn Schmiedebergs Arch Pharmacol; 1992 Jun; 345(6):627-32. PubMed ID: 1321956 [TBL] [Abstract][Full Text] [Related]
4. Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs. Werling LL; Frattali A; Portoghese PS; Takemori AE; Cox BM J Pharmacol Exp Ther; 1988 Jul; 246(1):282-6. PubMed ID: 2839666 [TBL] [Abstract][Full Text] [Related]
5. Characterization of opioid receptors on smooth muscle cells from guinea pig stomach. Zhang L; Gu ZF; Pradhan T; Jensen RT; Maton PN Am J Physiol; 1992 Mar; 262(3 Pt 1):G461-9. PubMed ID: 1312793 [TBL] [Abstract][Full Text] [Related]
6. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. Devine DP; Leone P; Pocock D; Wise RA J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399 [TBL] [Abstract][Full Text] [Related]
7. Opioid-receptor-mediated inhibition of [3H]dopamine but not [3H]noradrenaline release from rat mediobasal hypothalamus slices. Heijna MH; Padt M; Hogenboom F; Schoffelmeer AN; Mulder AH Neuroendocrinology; 1991 Aug; 54(2):118-26. PubMed ID: 1662785 [TBL] [Abstract][Full Text] [Related]
8. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum. Schoffelmeer AN; Hogenboom F; Mulder AH Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509 [TBL] [Abstract][Full Text] [Related]
9. Opioid receptor regulation of the release of norepinephrine in brain. Werling LL; Brown SR; Cox BM Neuropharmacology; 1987 Jul; 26(7B):987-96. PubMed ID: 2821438 [TBL] [Abstract][Full Text] [Related]
10. Identification of opioid receptors on gastric muscle cells by selective receptor protection. Grider JR; Makhlouf GM Am J Physiol; 1991 Jan; 260(1 Pt 1):G103-7. PubMed ID: 1670978 [TBL] [Abstract][Full Text] [Related]
11. Ontogeny of mu-, delta- and kappa-opioid receptors mediating inhibition of neurotransmitter release and adenylate cyclase activity in rat brain. De Vries TJ; Hogenboom F; Mulder AH; Schoffelmeer AN Brain Res Dev Brain Res; 1990 Jun; 54(1):63-9. PubMed ID: 2163782 [TBL] [Abstract][Full Text] [Related]
12. Ventral pallidal microinjections of receptor-selective opioid agonists produce differential effects on circling and locomotor activity in rats. Hoffman DC; West TE; Wise RA Brain Res; 1991 Jun; 550(2):205-12. PubMed ID: 1653084 [TBL] [Abstract][Full Text] [Related]
13. Effects of specific activation of mu-, delta- and kappa-opioid receptors on the secretion of luteinizing hormone and prolactin in the ovariectomized rat. Leadem CA; Yagenova SV Neuroendocrinology; 1987 Feb; 45(2):109-17. PubMed ID: 3033534 [TBL] [Abstract][Full Text] [Related]
14. Gastric effects of mu-, delta- and kappa-opioid receptor agonists on brainstem unitary responses in the neonatal rat. Yuan CS Eur J Pharmacol; 1996 Oct; 314(1-2):27-32. PubMed ID: 8957215 [TBL] [Abstract][Full Text] [Related]
15. Role of central mu, delta-1, and kappa-1 opioid receptors in opioid-induced muscle rigidity in the rat. Vankova ME; Weinger MB; Chen DY; Bronson JB; Motis V; Koob GF Anesthesiology; 1996 Sep; 85(3):574-83. PubMed ID: 8853088 [TBL] [Abstract][Full Text] [Related]
16. In vivo treatment with mu and delta, but not kappa-selective opioid agonists reduces [3H]spiperone binding to the guinea-pig striatum: autoradiographic evidence. Brent PJ; Bunn SJ Brain Res; 1994 Aug; 654(2):191-9. PubMed ID: 7987668 [TBL] [Abstract][Full Text] [Related]
17. Effects of intracerebroventricularly administered mu-, delta- and kappa-opioid agonists on locomotor activity of the guinea pig and the pharmacology of the locomotor response to U50,488H. Bot G; Chahl LA; Brent PJ; Johnston PA Neuropharmacology; 1992 Sep; 31(9):825-33. PubMed ID: 1359440 [TBL] [Abstract][Full Text] [Related]
18. Characterization of high affinity opioid binding sites in rat periaqueductal gray P2 membrane. Fedynyshyn JP; Kwiat G; Lee NM Eur J Pharmacol; 1989 Jan; 159(1):83-8. PubMed ID: 2540013 [TBL] [Abstract][Full Text] [Related]
19. Opioid receptors and inhibition of dopamine-sensitive adenylate cyclase in slices of rat brain regions receiving a dense dopaminergic input. Heijna MH; Bakker JM; Hogenboom F; Mulder AH; Schoffelmeer AN Eur J Pharmacol; 1992 Dec; 229(2-3):197-202. PubMed ID: 1337044 [TBL] [Abstract][Full Text] [Related]
20. Further evidence for a role of delta-opiate receptors in the presynaptic regulation of newly synthesized dopamine release. Petit F; Hamon M; Fournie-Zaluski MC; Roques BP; Glowinski J Eur J Pharmacol; 1986 Jul; 126(1-2):1-9. PubMed ID: 3019709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]